Major depression is a common and severe psychiatric disorder with a highly polygenic genetic 34 architecture. Genome-wide association studies have successfully identified multiple 35 independent genetic loci that harbour variants associated with major depression, but the exact 36 causal genes and biological mechanisms are largely unknown. Tissue-specific network 37 approaches may identify molecular mechanisms underlying major depression and provide a 38 biological substrate for integrative analyses. We provide a framework for the identification of 39 individual risk genes and gene co-expression networks using genome-wide association 40 summary statistics and gene expression information across multiple human brain tissues and 41 whole blood. We developed a novel gene-based method called eMAGMA that leverages multi-42 tissue eQTL information to identify 99 biologically plausible risk genes associated with major 43 depression, of which 58 are novel. Among these novel associations is Complement Factor 4A 44 (C4A), recently implicated in schizophrenia through its role in synaptic pruning during 45 postnatal development. Major depression risk genes were enriched in gene co-expression 46 modules in multiple brain tissues and the implicated gene modules contained genes involved 47 in synaptic signalling, neuronal development, and cell transport pathways. Modules enriched 48
Major Depression is a highly disabling mental health disorder that accounts for a sizable 75 proportion of the global burden of disease. The global lifetime prevalence of major depression 76 is around 12% (17% of women and 9% of men) (1), and ranks as the fourth most disabling 77 disorder in Australia in terms of years lived with disability (2). Major Depression has a complex 78 molecular background, driven in part by a highly polygenic mode of inheritance. A recent 79 genome-wide association study (GWAS) meta-analysis of 135,458 major depression cases and 80 344,901 controls identified 44 loci associated with the disorder (3). Detailed functional studies 81 showed these loci to be enriched in multiple brain tissues and neuronal cell types and to contain 82 common (minor allele frequency, MAF > 0.01) single nucleotide polymorphisms (SNPs) that 83 regulate the expression of multiple genes with putative roles in central nervous system 84 development and synaptic plasticity. These results suggest disease-associated SNPs modify 85 major depression susceptibility by altering the expression of their target genes in the brain. 86 Genes are known to interact and regulate the activity of one another in large gene-co-expression 87 networks. Therefore, SNPs may not only affect the activity of single target gene, but multiple 88 biologically related genes within the same tissue-specific co-expression network. The 89 integration of GWAS SNP genotype data with gene co-expression networks across multiple 90 tissues may be used to elucidate biological pathways and processes underlying highly 91 polygenic complex disorders such as major depression. 137 To assign major depression risk SNPs to genes, we applied two gene-based strategies: first, 138 proximity-based gene mapping with MAGMA, which assigns SNPs to the nearest gene within 139 a genomic window; and second, eQTL gene mapping using eMAGMA, which uses tissue-140 specific SNP-gene associations from GTEx to assign SNPs to genes based on their association 141 with gene expression. To further prioritise gene-level results, we performed a transcriptome-142 wide association study using S-PrediXcan. Both tissue-specific and P value thresholds for each 143 gene-based method, calculated using Bonferroni correction for the number of associations, are 144 shown in Table 1 . We identified 137 unique mapped depression-associated genes with 145 MAGMA (Table S2) , 217 significant tissue-specific gene associations with eMAGMA 146 (representing 99 unique mapped genes) (Table S3) , and 86 tissue-specific gene associations with S-PrediXcan (Table S4 ). A total of 41 genes were implicated by both MAGMA and 148 eMAGMA mapping strategies in at least one tissue ( Figure 1 ; Table S5 ). Among significant 149 eMAGMA associations, 35 (16%) also had a significant S-PrediXcan association in the same 150 tissue (Table S6) , and 16 associations were significant across all three gene-based methods 151 (Table 2) . Taken together, these results point to potential functional links for the GWAS-152 associated variants and give higher credibility to genes with convergent evidence of association 153 from multiple sources. Major depression risk genes are enriched in brain gene co-expression network modules 156 We tested for the enrichment of MAGMA (Table S2 ; N=137) and eMAGMA associations 157 (Table S3 ; N unique=99) in gene co-expression modules from the brain and whole blood. Gene 158 modules in four brain tissues (amygdala, cerebellar hemisphere, frontal cortex, and nucleus 159 accumbens) were enriched with MAGMA association signals, while one module in 160 hypothalamus and one module in putamen were enriched with eMAGMA associations (Table   161   4 ). Gene modules enriched with MAGMA remained significant after removal of genes in the 162 MHC region (Table S7) , however modules enriched with eMAGMA associations were no 163 longer significant after empirical multiple testing correction (Table S8 ). No enrichment of 164 gene-based association signals was observed for modules identified in whole blood, despite the 165 larger sample size (and hence increase power) compared to brain tissues. We plotted the 166 overlap in gene modules enriched with gene-based MD associations ( Figure S1 ). A total of 217 167 genes overlapped across four modules enriched with MAGMA associations, suggesting similar 168 biological processes may underlie the modular enrichments. On the other hand, we observed 169 little overlap in genes between modules enriched eMAGMA associations, suggesting tissue-170 specific eQTL effects may underlie these modular enrichments and highlighting the importance 171 of using both proximity-and eQTL-based gene-based tests.
Identification of risk genes for major depression

173
In gene pathway analyses of the major depression enriched modules, we found enrichment of 174 neuronal and synaptic signalling pathways in amygdala, frontal cortex, nucleus accumbens, 175 putamen (e.g. trans-synaptic signalling in frontal cortex, P=2.81 × 10 -24 ), as well as membrane 176 trafficking related pathways in cerebellar hemisphere (e.g. Membrane Trafficking, P=2.19 × 177 10 -13 ) and vascular-related pathways in hypothalamus (e.g. blood vessel morphogenesis, 178 P=5.67 × 10 -15 ) ( Figure 2 , Table S9 ). Pathway analysis of 217 genes overlapping four modules 179 enriched with MAGMA gene-based associations revealed chemical synaptic transmission 180 (GO:0007268; P=1.24 × 10 -14 ) and the neuronal system (R-HSA-112316; P=6.62 × 10 -10 ) 181 pathways (Table S10 ).
183
Gene co-expression modules enriched with major depression risk genes are preserved 184 across brain tissues 185 Our network-based approach allows the discovery of major depression associated gene 186 modules as well as the preservation (or reproducibility) of those associated modules across 187 tissues. We assessed the preservation of gene co-expression modules across brain tissues and 188 whole blood using the WGCNA modulePreservation algorithm, highlighting the preservation 189 of modules enriched with major depression GWAS signals. Strong modular preservation (Z 190 score > 10) was observed across all brain regions, while weak to moderate preservation was 191 observed in whole blood (Z score < 10) ( Supplementary Figure 2 Genome-wide association studies have provided important insight into the genetic architecture 199 of major depression. The next critical step is to leverage these genetic data to identify higher 200 order biological processes underlying the disorder, and to ultimately identify molecular targets 201 for risk prediction, diagnosis, and therapeutic intervention. To this end, we integrated multi-202 tissue gene expression data with major depression GWAS summary statistics using an 203 integrative network-based approach. We first applied a weighted gene co-expression network 204 analysis to gene expression data from multiple tissues in GTEx to measure the correlation 205 structure between protein-coding genes. The gene networks, which represent the 206 "connectedness" of genes in a given tissue, were divided into modules (or groups) of highly 207 correlated genes, under the assumption that correlated genes are involved in the same or similar 208 biological processes. The gene modules subsequently formed the unit of analysis for a) tests of 209 enrichment with major depression GWAS summary statistics; b) gene pathway analyses using 210 curated gene sets; and c) modular preservation (or replication) analyses across multiple tissues.
211
Our network-based approach identified novel gene candidates for major depression, and 212 identified co-expression networks enriched with biologically meaningful gene pathways that 213 were preserved across brain tissues.
214
A gene module approach based on gene co-expression patterns was used to identify groups of 215 functionally related genes associated with major depression. This approach reduced the 216 dimensionality of genome-wide gene expression data across multiple brain tissues and whole 217 blood without the loss of important biological information, and thereby alleviated the multiple 218 testing burden associated with traditional single gene-based methods. A similar network-based 219 approach has been applied to gene expression data for other brain-related disorders, including 220 post-traumatic stress syndrome (13), schizophrenia (14), and psychosis (15). However, these 221 studies typically included a small number of individuals (fewer than 100) from a single brain region and are therefore limited in their statistical power and generalisability across different 223 tissues. Our approach used a total of 216 individuals with a tissue sample from at least one of 224 13 brain regions, and 464 individuals with the inclusion of whole blood, thereby improving the 225 resolution and robustness of gene networks. Our network approach identified between 11 226 (Cortex) and 24 (Amygdala) mutually exclusive modules within tissues, and ranged in size 227 from 30 to 9144 genes. Each module was enriched with distinct and highly significant 228 biological pathways (e.g. immune signalling), suggesting our approach generated robust 229 modules of functionally related genes.
230
To identify genes and gene-sets associated with major depression, we assigned disease-231 associated SNPs to their nearest gene using both proximity and multi-tissue eQTL information. 232 We first used MAGMA, a proximity-based approach that assigns SNPs to their nearest gene.
233
This approach appropriately corrects for correlated SNPs (i.e. linkage disequilibrium [LD]), 234 and also adjusts for correlated gene expression in gene-set analysis and multiple-testing 235 correction. However, SNPs are simply assigned to their nearest gene based on an arbitrary 236 genomic window. It is well known that such proximity-based approaches often miss the 237 functional SNP-gene association (16). Therefore, we modified the MAGMA pipeline to 238 integrate SNPs with a significant (FDR<0.05) association with the expression of one or more 239 genes (eQTLs) from the multi-tissue GTEx resource. In doing so, we generated a tissue-240 specific, eQTL-informed MAGMA, or "eMAGMA", for the functional (i.e. biologically 241 meaningful) annotation of GWAS summary statistics.
242
Our eMAGMA approach identified novel and biologically meaningful candidate risk gene 243 associations for major depression across multiple tissues. Of 99 significant eMAGMA genes 244 (representing 217 unique gene-tissue associations), 58 were not identified by (proximity-based) 245 MAGMA. Noteworthy among these associations is Complement Factor 4A (C4A), recently 246 implicated in the development of schizophrenia through its role as a mediator of synaptic pruning during postnatal development (17). C4A was significant in 12 of 14 investigated 248 tissues, including whole blood, and was one of 24 significant eMAGMA genes located on 249 chromosome 6p21-a region with complex LD structure that flanks the centromeric end of the 250 major histocompatibility complex. While we cannot identify the causal gene due to the 251 complex LD pattern of the MHC region, this result suggests partially shared biological 252 pathways underlie both major depression and schizophrenia. 253 We tested for the enrichment of candidate risk genes in tissue-specific network co-expression 254 modules, while adjusting for correlated gene expression, gene size, and gene density. We We assessed the preservation (or reproducibility) of connectivity patterns (i.e. correlations) 270 between genes across multiple brain tissues and whole blood. This approach may determine 271 whether the connectivity between genes within a network module enriched with major depression signals differs both across brain tissues and between brain and whole blood, and 273 may therefore identify (peripheral) surrogate tissues for molecular studies of major depression. 274 We observed strong preservation of network modules across all brain regions, but not whole 275 blood, suggesting blood-based molecular studies of major depression may fail to capture 276 important disease-related processes in brain. Our findings therefore support the use of brain depression are likely to be identified. With these impending data, new methods for the 286 interpretation of genetic signals for major depression and other common complex disorders 287 will be required. Our network-based approach provides a gene expression substrate across 288 multiple human tissues for the integration and characterisation of GWAS signals. By exploiting 289 the connectivity between genes, this approach will allow the identification of perturbations in 290 the activity of a system rather than individual genes. Furthermore, network-based methods may 291 identify regulatory hubs whose perturbation may have wider consequences for major 292 depression and other (co-morbid) psychiatric and/or neurological disorders by virtue of their 293 interaction with other genes. Finally, gene co-expression networks can be integrated with other 294 molecular phenotypes, such as epigenetic DNA methylation, proteomics, and metabolomics 295 data, for 'omics-based analyses. Such 'omics-based analyses are critical for understanding the 296 properties of biological systems underlying complex disorders such as major depression.
Methods
299
The Genotype-Tissue Expression (GTEx) project 300 An overview of our analytical pipeline is shown in supplementary Figure 1 . Fully processed, 301 filtered and normalised gene expression data for 13 brain tissues and whole blood (Table 1) 302 were downloaded from the Genotype-Tissue Expression project portal (version 7) 303 (http://www.gtexportal.org) ( Table 1) . Only genes with ten or more donors with expression Gene-level analysis of Major Depression GWAS signals 350 We identified and prioritised risk genes for major depression using three approaches. First, we nearby SNPs. Second, we modified the MAGMA approach by integrating eQTL information 356 from the GTEx project. That is, for a given interrogated tissue, we assigned SNPs to target 357 genes based on significant (FDR<0.05) SNP-gene associations in GTEx. This approach, which 358 we will refer to as "eMAGMA", is a tissue-specific, eQTL-informed method for assigning 359 SNPs to genes. Gene-based statistics were subsequently computed using the sum of the 360 assigned SNP -log(10) P values, in a similar manner to proximity-based MAGMA. Third, we 361 used S-PrediXcan to integrate eQTL information from GTEx with major depression GWAS 362 summary statistics to identify genes whose genetically predicted expression levels are 363 associated with major depression. For S-PrediXcan, we used expression weights for 13 brain 364 tissues and whole blood generated from GTEx (v7) (25), and LD information from the 1000 365 Genomes Project Phase 3 (26). These data were processed with beta values and standard errors 366 from the GWAS of major depression (3) to estimate the expression-GWAS association statistic.
367
For each gene-level approach, we corrected for multiple testing using Bonferroni correction.
368
For MAGMA, we corrected for the total number of genes tested (i.e. 0.05/18,041 = 2.77 × 10 -369 6 ). For the multi-tissue eMAGMA and S-PrediXcan, we applied two correction thresholds 370 (Table 1) : a "liberal" threshold, which corrected for the number of tests within each tissue (i.e.
ignoring the number of tissues tested), and a "conservative" threshold, which corrected for the 372 total number of tests performed (i.e. all tests across all tissues).
374
Gene-set analysis of gene co-expression modules 375 To identify gene co-expression modules enriched with major depression risk genes, we 376 performed gene-set analysis of both (proximity) MAGMA and eMAGMA gene-level results 377 in tissue-specific gene co-expression modules using the gene-sets analysis function in 378 MAGMA v1.06. The competitive analysis tests whether the genes in a gene-set (i.e. gene co-379 expression module) are more enriched with major depression risk genes than other genes while 380 accounting for gene size and gene density. We applied an adaptive permutation procedure (24) 381 (N=10,000 permutations) to obtain P values corrected for multiple testing. The 1000 Genomes tailed test for gene pathway enrichment; the smaller the P value, the lower the probability a 394 gene belongs to both a co-expression module and a biological term or pathway purely by 395 chance. Multiple testing correction was done using g:SCS; this approach accounts for the correlated structure of GO terms and biological pathways, and corresponds for an experiment-397 wide threshold of α=0.05.
399
Preservation of gene co-expression networks across tissues 400 To examine the tissue-specificity of biological pathways, we assessed the preservation (i.e. 401 replication) of network modules across GTEx tissues using the "modulePreservation" R 402 function implemented in WGCNA (30) . Briefly, the module preservation approach takes as 403 input "reference" and "test" network modules and calculates statistics for three preservation 404 classes: i) density-based statistics, which assess the similarity of gene-gene connectivity 405 patterns between a reference network module and a test network module; ii) separability-based 406 statistics, which examine whether test network modules remain distinct in reference network 407 modules; and iii) connectivity-based statistics, which are based on the similarity of connectivity 408 patterns between genes in the reference and test networks. For simplicity, we report two density 409 and connectivity composite statistics: "Zsummary" and "medianRank". A Zsummary value 410 greater than 10 suggests there is strong evidence a module is preserved between the reference 411 and test network modules, while a value between 2 and 10 indicates weak to moderate 412 preservation and a value less than 2 indicates no preservation. The median rank statistic ranks 413 the observed preservation statistics; modules with lower median rank tend to exhibit strong 414 preservation than modules with higher median rank. Notes: The full list of results for MAGMA, eMAGMA, and S-PrediXcan are listed in Table S2 , Table S3 , and Table S4 , respectively. Notes: Module enrichment analyses was performed using MAGMA. Beta: regression coefficient of the gene set; SE, the standard error of the regression coefficient; P the competitive gene-set P value; P corr: P value empirically corrected for multiple testing for all the gene set. Figure 1 : Overlap in the number of significant gene-level associations between MAGMA, eMAGMA, and S-PrediXcan.
Notes: Significant MAGMA genes (N=137) were selected using Bonferroni correction for the entire list of gene-based P values (i.e. 0.05/18042=2.77×10 -6 ). Significant eMAGMA (N=99) and S-PrediXcan (N=57) results were adjusted using Bonferroni correction for the number of associations in each tissue (see Table 1 for tissue-specific thresholds). The overlap between gene-level results after correcting for all tissues and genes (N=51,501, P=9.71×10 -7 ) is presented in Figure S1 . Refer to Table 3 for the top (N=10) overlapping significant gene-based associations for MAGMA, eMAGMA, and S-PrediXcan, and Table S5 for the entire list of gene-based results (N=41).
Figure 2: Pathway analysis of major depression enriched modules
Notes: A competitive gene pathway analysis was performed on tissue-specific significant gene co-expression modules using g:Profiler (https://biit.cs.ut.ee/gprofiler/index.cgi). The figure shows the gene ontology and biological pathways of tissue-specific modules enriched with major depression gene-based signals.
Figure 3:
Preservation of major depression enriched network modules across brain tissues and whole blood. (A) Preservation Z score for tissue-specific modules (labelled M1 to M6 on the y axis) across brain tissues and whole blood. A higher Z score indicates greater preservation (i.e. replication) of a "reference" network in a "test" network (and vice versa). (B) Categorical classification of preservation Z scores across brain tissues and whole blood. A Z score less than 2 indicates no modular preservation; a Z score between 2 and 10 indicates weak to moderate preservation; and a Z score greater than 10 indicates strong preservation.
